Journal List > Pediatr Allergy Respir Dis > v.21(3) > 1033129

Park, Chung, Shim, Kim, Jung, Park, and Shim: The Relationship between Atopic Dermatitis, Thymus and Activation-Regulated Chemokine/CCL17, Quality of Life, and Attention Deficit-Hyperactivity Disorder in Preschool Children

Abstract

Purpose

Atopic dermatitis may impair quality of life and lead to attention deficit-hyperactivity disorder (ADHD). Thymus and activation-regulated chemokine (TARC)/CCL17 may serve as a new biomarker for atopic dermatitis. We investigated the relationship between TARC and the severity of atopic dermatitis, quality of life, and ADHD.

Methods

A total of 249 preschool children who had atopic dermatitis were enrolled. Parents of the patients filled out a questionnaire on the past history of allergic diseases, quality of life, and ADHD. In each patient, total immunoglobulin (Ig) E and specific IgE to nine foods and inhalant allergens, total eosinophil counts, and TARC levels were measured. We evaluated the severity of atopic dermatitis by using the scoring atopic dermatitis (SCORAD) score and divided the patients into three groups; mild (<15), moderate (15 to 40), and severe (>40).

Results

In a total of 249 children, 222 children (89.2%) had a history of atopic dermatitis. Children with allergic sensitization had a higher SCORAD score, total IgE levels, and total eosinophil counts, but not TARC levels. Three groups by the SCORAD score showed significant differences in quality of life index and TARC levels but not in ADHD index. TARC level was correlated with the SCORAD score, but not with the quality of life index and ADHD index. The SCORAD score was correlated with the quality of life index but not with the ADHD index.

Conclusion

Serum TARC levels may be associated with the severity of atopic dermatitis but not with the degree of quality of life and ADHD. Disease severity of atopic dermatitis in preschool children may be associated with the degree of quality of life but not with the level of ADHD.

References

1. Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol. 2000; 43:649–55.
crossref
2. Hong SJ, Lee MS, Sohn MH, Shim JY, Han YS, Park KS, et al. Self-reported prevalence and risk factors of asthma among Korean adolescents: 5-year follow-up study, 1995–2000. Clin Exp Allergy. 2004; 34:1556–62.
crossref
3. Wollenberg A, Bieber T. Atopic dermatitis: from the genes to skin lesions. Allergy. 2000; 55:205–13.
crossref
4. Wollenberg A, Kraft S, Oppel T, Bieber T. Atopic dermatitis: pathogenetic mechanisms. Clin Exp Dermatol. 2000; 25:530–4.
crossref
5. Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci. 2010; 58:1–7.
crossref
6. Fujisawa T, Nagao M, Hiraguchi Y, Katsumata H, Nishimori H, Iguchi K, et al. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Pediatr Allergy Immunol. 2009; 20:633–41.
crossref
7. Furusyo N, Takeoka H, Toyoda K, Murata M, Maeda S, Ohnishi H, et al. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS). Eur J Dermatol. 2007; 17:397–404.
8. Song TW, Sohn MH, Kim ES, Kim KW, Kim KE. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis. Clin Exp Allergy. 2006; 36:346–51.
crossref
9. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol. 2000; 115:640–6.
crossref
10. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol. 2002; 110:139–46.
crossref
11. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol. 2001; 107:535–41.
crossref
12. Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol. 2004; 150:284–90.
crossref
13. Ben-Gashir MA. Relationship between quality of life and disease severity in atopic dermatitis/eczema syndrome during childhood. Curr Opin Allergy Clin Immunol. 2003; 3:369–73.
crossref
14. Gånemo A, Svensson A, Lindberg M, Wahlgren CF. Quality of life in Swedish children with eczema. Acta Derm Venereol. 2007; 87:345–9.
crossref
15. Romanos M, Gerlach M, Warnke A, Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health. 2010; 64:269–73.
crossref
16. Schmitt J, Romanos M, Schmitt NM, Meurer M, Kirch W. Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA. 2009; 301:724–6.
crossref
17. Hon KL, Lam MC, Wong KY, Leung TF, Ng PC. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P. Br J Dermatol. 2007; 157:922–5.
crossref
18. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19:210–6.
crossref
19. Achenbach TM, Edelbrock C, Howell CT. Empirically based assessment of the behavioral/emotional problems of 2-and 3-year-old children. J Abnorm Child Psychol. 1987; 15:629–50.
20. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993; 186:23–31.
21. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol. 2003; 120:932–41.
crossref
22. Park JH, Choi YL, Namkung JH, Kim WS, Lee JH, Park HJ, et al. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol. 2006; 155:778–83.
crossref
23. Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol. 2006; 118:214–9.
crossref
24. Weidinger S, Rodríguez E, Stahl C, Wagenpfeil S, Klopp N, Illig T, et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol. 2007; 127:724–6.
crossref
25. Leung TF, Wong CK, Chan IH, Ip WK, Lam CW, Wong GW. Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma. J Allergy Clin Immunol. 2002; 110:404–9.
crossref
26. Murat-Susić S, Lipozencić J, Zizić V, Husar K, Marinović B. Serum eosinophil cationic protein in children with atopic dermatitis. Int J Dermatol. 2006; 45:1156–60.
crossref
27. Mostafa GA, Tomoum HY, Salem SA, Abd El-Aziz MM, Abou El-Maged DI, El-Sayed El-Far I. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children. Pediatr Allergy Immunol. 2008; 19:756–62.
crossref
28. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol. 2004; 113:334–40.
29. Leung TF, Wong CK, Lam CW, Li AM, Ip WK, Wong GW, et al. Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. Eur Respir J. 2003; 21:616–20.
crossref
30. Takeuchi H, Yamamoto Y, Kitano H, Enomoto T. Changes in thymus-and activation-regulated chemokine (TARC) associated with allergen immunotherapy in patients with perennial allergic rhinitis. J Investig Allergol Clin Immunol. 2005; 15:172–6.
31. Al Robaee AA, Shahzad M. Impairment quality of life in families of children with atopic dermatitis. Acta Dermatovenerol Croat. 2010; 18:243–7.
32. Lapidus CS, Kerr PE. Social impact of atopic dermatitis. Med Health R I. 2001; 84:294–5.
33. Raap U, Werfel T, Jaeger B, Schmid-Ott G. Atopic dermatitis and psychological stress. Hautarzt. 2003; 54:925–9.
34. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005; 366:237–48.
crossref

Fig. 1.
Correlations of scoring atopic dermatitis (SCORAD) index with serum thymus and activation-regulated chemokine (TARC) level, quality of life (QoL) index and attention deficit/hyperactivity disorder (ADHD) index. SCORAD index showed significant correlation with serum TARC level (A) and QoL index (B), but not with ADHD index (C).
pard-21-215f1.tif
Fig. 2.
Correlation of serum thymus and activation-regulated chemokine (TARC) level with quality of life (QoL) index and attention deficit/hyperacti-vity disorder (ADHD) index. Serum TARC level was not correlated with either QoL index (A) or ADHD index (B).
pard-21-215f2.tif
Table 1.
Demographic Characteristics of the Study Subjects (n=249)
Demographic characteristics Value
Male 126 (50.6)
Age (mo) 49±23
History of atopic dermatitis 222 (89.2)
History of asthma 38 (15.3)
History of History of allergic rhinitis 73 (29.3)
History of urticaria 136 (54.6)

Values are presented as number (%) or mean±SD.

Table 2.
Comparison of SCORAD Score, Total IgE Levels, Total Eosinophil Counts and TARC Levels between Atopy and Non-atopy Children
  Atopy P -value
–(n=124) +(n=125)
SCORAD score 12.9±9.8 16.6±11.1 0.005
Serum total IgE (IU/mL) 75.9±115.6 398.2±582.2 0.001
Total eosinophil count (/mm3) 408.0±704.6 727.0±1448.6 0.028
TARC (pg/mL) 1178.7±769.4 1171.0±634.4 0.931

Values are presented as mean±SD.

SCORAD, scoring atopic dermatitis; IgE, immunoglobulin E; TARC, thymus and activation-regulated chemokine.

Atopy, more than 1 specific IgE≥0.35 KUA/L.

Table 3.
Comparison of TARC Level, QoL Index and ADHD Index by Severity of Atopic Dermatitis
Severity of atopic dermatitis Mild (n=141) Moderate (n=98) Severe (n=10) P-value
TARC (pg/mL) 1060.2±638.4 1278.1±699.8 1778.4±1137.7 0.008
QoL index 2.95±3.32 5.90±4.33 9.40±4.72 0.001
ADHD index 8.97±8.06 10.60±8.44 9.20±8.08 0.302

Values are presented as mean±SD.

TARC, thymus and activation-regulated chemokine; QoL, quality of life; ADHD, attention deficit/hyperactivity disorder.

Mild, SCORAD index <15; moderate, SCORAD index 15 to 40; severe, SCORAD index >40.

TOOLS
Similar articles